Bank Of America Corp Galapagos Nv Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Galapagos Nv stock. As of the latest transaction made, Bank Of America Corp holds 35,263 shares of GLPG stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,263

Previous 6,494 443.01%

Holding current value

$1.07 Million

Previous $209,000 317.7%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.78 - $32.48 $712,895 - $934,417	28,769 Added 443.01%	35,263 $873,000
Q1 2024 May 15, 2024	SELL	$32.2 - $42.44 $461,039 - $607,655	-14,318 Reduced 68.8%	6,494 $209,000
Q4 2023 Feb 14, 2024	BUY	$31.87 - $40.71 $16,827 - $21,494	528 Added 2.6%	20,812 $846,000
Q2 2023 Aug 14, 2023	BUY	$37.4 - $44.52 $156,369 - $186,138	4,181 Added 25.96%	20,284 $824,000
Q1 2023 May 12, 2023	BUY	$36.5 - $48.0 $484,355 - $636,960	13,270 Added 468.41%	16,103 $622,000
Q4 2022 Feb 10, 2023	SELL	$37.44 - $46.51 $72,858 - $90,508	-1,946 Reduced 40.72%	2,833 $125,000
Q3 2022 Nov 14, 2022	BUY	$42.27 - $57.6 $30,180 - $41,126	714 Added 17.56%	4,779 $204,000
Q2 2022 Aug 12, 2022	SELL	$52.3 - $71.59 $62,916 - $86,122	-1,203 Reduced 22.84%	4,065 $226,000
Q1 2022 May 16, 2022	SELL	$51.32 - $68.5 $1.73 Million - $2.31 Million	-33,744 Reduced 86.5%	5,268 $326,000
Q4 2021 Feb 08, 2022	BUY	$47.03 - $57.12 $1.42 Million - $1.73 Million	30,269 Added 346.21%	39,012 $2.15 Million
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $216,714 - $291,610	4,154 Added 90.52%	8,743 $460,000
Q2 2021 Sep 13, 2021	BUY	$68.86 - $83.34 $315,998 - $382,447	4,589 New	4,589 $316,000

Others Institutions Holding GLPG

# of Institutions

Shares Held

17.4M

Call Options Held

10.4K

Put Options Held

33.1K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $2B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Galapagos Nv Transaction History